期刊文献+

攻坚散联合乳腺治疗仪治疗乳腺增生症100例 被引量:2

Gongjian Powder Combined with Breast Therapeutic Instrument in the Treatment of Cyclomastopathy for 100 Cases
下载PDF
导出
摘要 目的观察中药攻坚散加减配合乳腺病治疗仪理疗治疗乳腺增生症的临床疗效。方法回顾性分析2015年2月—2017年2月收治的160例乳腺增生症患者,根据治疗方式的不同分成2组,治疗组给予中药攻坚散加减口服配合乳腺病治疗仪理疗,对照组给予口服逍遥丸及维生素E、维生素B6治疗,观察2组临床疗效和治疗前后血清性激素水平。结果治疗后治疗组总有效率显著高于对照组,差异有统计学意义(P<0.05)。治疗后2组血清雌二醇(E2)、垂体催乳素(PRL)水平下降,治疗组明显优于对照组(P<0.05)。结论应用中药攻坚散加减联合乳腺治疗仪治疗乳腺增生症临床疗效显著,值得临床推广应用。 Objective To observe the clinical effect of Gongjian powder combined with breast therapeutic instrument in the treatment of cyclomastopathy. Methods Retrospective analysis on 160 cases of cyclomastopathy patients during February 2015 to February 2015 was made. According to the different methods of treatment, they were divided into two groups. The treatment group was given traditional Chinese medicine crucial adjustment of oral with mammary gland disease therapeutic apparatus physical therapy, and the control group was given oral Xiaoyao pill and vitamin E, vitamin B6. The clinical curative effect and serum sex hormone levels before and after the treatment were observed. Results The total effective rate after treatment was significantly higher than that in the control group, and the difference between the two groups was statistically significant( P〈0.05). After treatment, the serum estradiol(E2) and pituitary prolactin( PRL) decreased, and the treatment group was significantly better than the control group( P〈0.05). Conclusion The Gongjian powder combined with breast therapeutic instrument in the treatment of cyclomastopathy has significantly curative effect, and is worthy of clinical popularization and application.
作者 杨春雷 刘秋蓓 YANG Chunlei;LIU Qiubei(General Surgery, Yingtan Hospital of Traditional Chinese Medicine, Jiangxi Province, Yingtan 335000, Chin)
出处 《中国中医药现代远程教育》 2018年第9期115-117,共3页 Chinese Medicine Modern Distance Education of China
基金 江西省卫生计生委中医药课题【No.2016B141】
关键词 乳腺增生症 攻坚散 乳腺病治疗仪 雌二醇 垂体催乳素 乳癖 理疗 cyclomastopathy Gongjian powder breast therapeutic instrument Estradiol pituitary prolactin lump in breast physiotherapy
  • 相关文献

参考文献4

二级参考文献75

  • 1杜红文,张毅力,张蕴,张月浪,徐贵平.乳腺增生症的影像学诊断[J].中国医学影像学杂志,2007,15(4):270-273. 被引量:9
  • 2杜红文,张蕴.乳腺疾病影像诊断学[M].西安:陕西科技出版社,2007:89.
  • 3鲍润贤.中华影像医学(乳腺卷)[M].北京:人民卫生出版社,2002.66-79.
  • 4刘复生.中国肿瘤病理学分类[M].北京:科学技术文献出版社,2001.225-226.
  • 5邵志敏,沈镇宙,徐兵河,主编.乳腺肿瘤学[M].上海:复旦大学出版社,2013: 24-25.
  • 6Socolov D, Anghelache I, Ilea C, et al. Benign breast disease and the risk of breast cancer in the next 15 years[J]. Rev Med Chir Soc Med Nat Iasi,2015,119( 1 ): 135 - 140.
  • 7La Rosa S, Sessa F, Colombo L, et al. Expression of acidic fibro- blast growth factor (aFGF) and fibroblast growth factor receptor 4 (FGFR4) in breast fibroadenomas [J]. J Clin Pathol,2001, 54(1): 37-41.
  • 8Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease[J]. N Engl J Med,1985, 312 (3): 146-151.
  • 9Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of Ameri- can Pathologists [J]. Arch Pathol Lab Med, 1998, 122(12): 1053-1055.
  • 10Page DL, Schuyler PA, Dupont WD, et al. Atypical lobular hy- perplasia as a unilateral predictor of breast cancer risk: a retro- spective cohort study [ J ]. Lancet, 2003, 361 (9352): 125-129.

共引文献340

同被引文献24

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部